We intend to strategically partner with pharmaceutical and biotechnology companies, universities, government agencies, foundations and advocacy groups to assemble the assets and resources necessary for success.

Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines in more than 20 therapeutic categories. The company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service. For more information, please visit www.merck.com.

FRAXA Research Foundation was founded in 1994 to support scientific research aimed at finding a treatment and a cure for fragile X. Fragile X research is underfunded, considering its high prevalence, prospects for a cure, and the promise that Fragile X research holds for advancing our understanding of other disorders like autism, Alzheimer's disease, and X-linked mental retardation. FRAXA funds grants and fellowships at universities all over the world. For more information, please visit www.fraxa.org.

Correlagen Diagnostics, Inc., is a molecular diagnostics company located in Cambridge, Massachusetts. Correlagen's mission is to promote the broad use of gene testing in clinical practice thereby improving the diagnosis and treatment of disease. Rapid advances in human genomics and genetics have greatly increased the potential of gene sequence analysis for diagnostic use. Correlagen offers a full line of products and services that range from test development to clinical interpretation of gene sequencing results. For more information, please visit www.correlagen.com.

Next: Careers »